Segall Bryant & Hamill’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.3M Buy
2,362,049
+11,303
+0.5% +$82.6K 0.24% 141
2025
Q1
$22.3M Buy
2,350,746
+236,924
+11% +$2.25M 0.34% 93
2024
Q4
$34.8M Buy
2,113,822
+220,415
+12% +$3.63M 0.48% 53
2024
Q3
$27.9M Buy
1,893,407
+759,524
+67% +$11.2M 0.38% 81
2024
Q2
$15.7M Sell
1,133,883
-198,098
-15% -$2.75M 0.28% 117
2024
Q1
$20.9M Sell
1,331,981
-25,456
-2% -$400K 0.39% 89
2023
Q4
$22M Sell
1,357,437
-2,186
-0.2% -$35.4K 0.42% 74
2023
Q3
$16.7M Buy
1,359,623
+18,549
+1% +$228K 0.19% 139
2023
Q2
$21.6M Buy
1,341,074
+220,018
+20% +$3.54M 0.23% 123
2023
Q1
$19.5M Buy
1,121,056
+52,343
+5% +$911K 0.21% 134
2022
Q4
$9.87M Sell
1,068,713
-43,161
-4% -$399K 0.11% 221
2022
Q3
$9.58M Buy
+1,111,874
New +$9.58M 0.11% 212
2021
Q4
Sell
-39,654
Closed -$1.91M 690
2021
Q3
$1.91M Sell
39,654
-40,345
-50% -$1.95M 0.02% 466
2021
Q2
$3.61M Sell
79,999
-27,821
-26% -$1.26M 0.04% 384
2021
Q1
$5.2M Sell
107,820
-5,078
-4% -$245K 0.05% 328
2020
Q4
$6.08M Sell
112,898
-10,327
-8% -$556K 0.07% 260
2020
Q3
$4.55M Buy
123,225
+2,639
+2% +$97.4K 0.06% 274
2020
Q2
$3.73M Sell
120,586
-12,134
-9% -$376K 0.06% 261
2020
Q1
$3.66M Buy
132,720
+7,924
+6% +$219K 0.07% 243
2019
Q4
$3.65M Sell
124,796
-87,706
-41% -$2.57M 0.06% 297
2019
Q3
$4.07M Sell
212,502
-2,078
-1% -$39.8K 0.06% 304
2019
Q2
$4.71M Sell
214,580
-18,009
-8% -$395K 0.07% 286
2019
Q1
$4.76M Sell
232,589
-36,381
-14% -$745K 0.07% 276
2018
Q4
$3.39M Sell
268,970
-23,420
-8% -$295K 0.06% 315
2018
Q3
$4.49M Sell
292,390
-60,274
-17% -$925K 0.07% 309
2018
Q2
$4.62M Sell
352,664
-88,716
-20% -$1.16M 0.07% 305
2018
Q1
$3.6M Buy
441,380
+6,952
+2% +$56.7K 0.08% 247
2017
Q4
$3.85M Buy
434,428
+60,360
+16% +$535K 0.08% 233
2017
Q3
$4.16M Buy
374,068
+284,572
+318% +$3.17M 0.1% 221
2017
Q2
$802K Buy
+89,496
New +$802K 0.02% 382